Designation/Position- India-U.S. Collaborative Vision Research
Department of Biotechnology & NEI-NIH invites application for India-U.S. Collaborative Vision Research Program Funding Opportunity-2020
About- Scientific collaborations between India and the U.S.have been successfully conducted for several years under a variety of bilateral agreements. Recognizing that continuing collaborative research focused on eye diseases and visual disorders would be of mutual benefit to India and the U.S., the Indian Department of Biotechnology (DBT), the U.S. National Eye Institute (NEI), and a Joint Working Group (JWG) developed a strategic plan for collaborations and to facilitate the expedited review and clearance of proposed bilateral projects. Both the DBT and the NEI have pledged funds to support joint activities pursued under this bilateral program. India-U.S. Collaborative Vision Research
Research/Job Area- Biotechnology
More Opportunities:-
Killam Postdoctoral Research Fellowships – 2020 in Canadian universities
Research Associate at University of Leicester, UK- Apply by 06 Oct….
Jawaharlal Nehru Post-Doc Fellowships, TIFR, ₹ 55,000 -75,000/month
Postdoc Position at IIT Ropar -Last Date – 20 October 2020
Berlin Mathematical School PhD Program – Freie Universität Berlin
Hong Kong PhD Fellowship Scheme (HKPFS), Up to 300 Ph.D. Fellowships
Hans Böckler Foundation: Ph.D. scholarship at German institutions of higher education
Research Associate & Scientist Positions at GenVynn Biologics Pvt. Ltd.
Eligibility/Qualification–
- India – Entities eligible to participate:
- Government of India supported or recognized (Public or Private) academia; research organizations.
- Government of India recognized not-for-profit, NGO(s)/ Voluntary Organization(s)(VOs)/Trust(s)/ Research foundations, having research as one of the imperative mandates.
- U.S – Entities eligible to participate:
- Any natural or legal person /entity (e.g. any company, big or small, research organizations, universities, non-governmental organizations, etc.) regardless of their place of residence or establishment in U.S.
- They must possess the operational and financial viability to carry out the research tasks that they propose.
- Program Directors/Principal Investigators (PD(s)/PI(s)
- All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
- Eligible Individuals (Program Director (PD) /Principal Investigator (PI)
- Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
- For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
- Additional Information on Eligibility:
- Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
- The DBT & NIH will not accept duplicate or highly overlapping applications under review at the same time.
Job/Position Description-
- Participating Organization(s): Department of Biotechnology & NEI-NIH
- Funding Opportunity Title: India-U.S. Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
- Activity Code: R01 Research Project Grant (for DBT)
- Funding Opportunity Purpose: This Funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.) and Indian institution as bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications.
- Areas of Research Collaboration: Applications are encouraged from organization/institutions that propose to conduct research on the basic biology and/or genetics of ophthalmic diseases through collaborations with Indian investigators on the following: diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pigmentosa, including rare and genetic diseases such as congenital cataracts, as well as other eye conditions such as ocular inflammation/uveitis, refractive error, low vision, and corneal injury. Basic, translational, or epidemiological research may be proposed. Clinical trials will not be supported under this FOA.
- Funding: All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
- Open Date (Earliest Submission Date): September 14,2020
- NIH weblink for application form: https://grants.nih.gov/grants/guide/pa-files/par-18-912.html
How to Apply-
Each application needs to be submitted to both DBT & NIH
Required Registrations
Applicant organizations must complete and maintain several registrations as described in the NIH SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the US application being submitted. Registration can take 6 weeks or more, so applicant organizations should begin the registration process as soon as possible. In addition, all PD(s)/PI(s) must have an NIH eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. The processes and timelines for applicant organization and PD/PI registrations are detailed at: https://grants.nih.gov/grants/how-to-apply-application-guide/prepare-to-apply-andregister/register.htm.
- Dun and Bradstreet Universal Numbering System (DUNS) – All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
- System for Award Management (SAM) (formerly CCR) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
- NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM.
- eRA Commons – Applicants must have an active DUNS number and SAM registration in order to complete the eRA Commons registration. Organizations can register with the eRA Commons as they are working through their SAM or Grants.gov registration. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
Grants.gov – Applicants must have an active DUNS number and SAM registration in order to complete the Grants.gov registration.
Requesting an Application Package
Buttons to access the online ASSIST system or to download application forms are available in the link below. See your administrative office for instructions if you plan to use an institutional system-to-system solution.
Content and Form of Application Submission
The Indian and US participants should formulate a joint proposal according to the requirements and templates provided by the NIH.It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
For information on Application Submission and Receipt, visit Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications
Page Limitations– All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed
Instructions for Application Submission
The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.
- SF424(R&R) Cover – All instructions in the SF424 (R&R) Application Guide must be followed.
- SF424(R&R) Project/Performance Site Locations – All instructions in the SF424 (R&R) Application Guide must be followed.
- SF424(R&R) Other Project Information -All instructions in the SF424 (R&R) Application Guide must be followed.
- Other Attachments: Applications are required to include a Collaborative Strategy. The Collaborative Strategy should include a description of how the proposed collaboration will be maintained throughout the duration of the award. The following areas should be addressed:
- Organizational structure
- Management plan detailing how existing resources will be utilized
- Planned interaction and responsibilities of key personnel
- Description of how research teams will communicate (e.g.,video/teleconference, web meeting)
- Plans for making decisions and procedures for resolving conflicts
- Available resources (e.g. patient samples, data, and reagents) and details of how these resources will be shared as appropriate.
- How the collaboration brings complementary or unique expertise to the project that will enhance the research and stimulates collaborative basic, translational, or applied research between Indian researchers and U.S.-based researchers.
- Provide the information as a single PDF file with the name “Collaboration.pdf.”
- SF424(R&R) Senior/Key Person Profile– Must follow all instructions in the SF424 (R&R) Application Guide.
- R&R Modular Budget– Must follow all instructions in the SF424 (R&R) Application Guide.
- R&R Subaward Budget-Must follow all instructions in the SF424 (R&R) Application Guide.
- PHS 398 Cover Page Supplement-Must follow all instructions in the SF424 (R&R) Application Guide
- PHS 398 Research Plan– Must follow all instructions in the SF424 (R&R) Application Guide with the following additional instructions:
- Letters of Support: Applicants must include a Letter of Support co-written and co-signed by the PD(s)/PI(s) of the NIH application and the Indian collaborating partner and co-signed by the authorizing institutional officials confirming the new or existing collaboration and confirming that the U.S. awardee organization will provide a copy of the NIH submitted application to the DBT through their Indian collaborating partner.
- Resource Sharing Plan: Individuals must comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide.
- The following modifications also apply:
- All applications, regardless of the amount of direct costs requested for any one year, should address a Data Sharing Plan.
- Appendix: Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.
- PHS Human Subjects and Clinical Trials Information -When involving NIH-defined human subjects research, clinical research, and/or clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:
- If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.
- Study Record: PHS Human Subjects and Clinical Trials Information-Must follow all instructions in the SF424 (R&R) Application with the following additional instructions.
SUBMIT THE COMPLETE APPLICATION PACKAGE TO DBT (AS PDF DOCUMENT) PRIOR TO CLOSURE OF THE CALL. SUBMIT THE APPLICATION ELECTRONICALLY AT: jyoti.logani@nic.in
IN CASE OF NON-SUBMISSION TO DBT THE PROPOSAL WILL NOT BE CONSIDERED FOR FURTHER PROCESSING.
Also submit one hard copy addressed to the Programme Officer as per the details below:
Dr. Jyoti M. Logani
Scientist E
Room No. 811, Eighth Floor
Block-2, DBT, CGO Complex
New Delhi-110003
E-mail address: jyoti.logani@nic.in
Last Date for Apply– 09 November 2020
Join Our Discussion Forum – Keep your view, share knowledge/opportunity and ask your questions
